These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15918985)

  • 21. Severe generalized pustular psoriasis treated with mycophenolate mofetil.
    Ji YZ; Geng L; Ma XH; Wu Y; Zhou HB; Li B; Xiao T; Chen HD
    J Dermatol; 2011 Jun; 38(6):603-5. PubMed ID: 21352286
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycophenolate mofetil--a new treatment for autoimmune hepatitis?
    Dhawan A; Mieli-Vergani G
    J Hepatol; 2000 Sep; 33(3):480-1. PubMed ID: 11020006
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
    Czaja AJ
    J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Schramm C; Lohse AW
    J Hepatol; 2011 Sep; 55(3):510-511. PubMed ID: 21281682
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil.
    Haeberle MT; Adams WB; Callen JP
    Arch Dermatol; 2012 Aug; 148(8):887-8. PubMed ID: 22911181
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C and mycophenolate mofetil--a clarification.
    Fasola CG; Klintmalm GB
    Liver Transpl; 2002 Apr; 8(4):411-2; author reply 412-3. PubMed ID: 11965590
    [No Abstract]   [Full Text] [Related]  

  • 28. Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil.
    Gladstone DE
    Leuk Res; 2008 Sep; 32(9):1487-8. PubMed ID: 18378308
    [No Abstract]   [Full Text] [Related]  

  • 29. Progression of lupus nephritis during treatment with mycophenolate mofetil.
    Ahmadi-Simab K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2004 Sep; 63(9):1179-80. PubMed ID: 15308535
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate mofetil (MMF) for refractory chronic graft versus host disease (cGvHD).
    Castagna L
    Haematologica; 2003 Aug; 88(8):ELT28; author reply ELT29. PubMed ID: 12935991
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycophenolate mofetil in minimal change nephrosis.
    Alfred R; Soyibo AK
    West Indian Med J; 2010 Jun; 59(3):330-1. PubMed ID: 21291117
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids.
    Grotz W; von Zedtwitz I; Andre M; Schollmeyer P
    Lancet; 1998 Oct; 352(9135):1195. PubMed ID: 9777843
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic actinic dermatitis with mycophenolate mofetil].
    Weidgang K; Diesler S; Krieg T; Hunzelmann N
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):702-4. PubMed ID: 16173979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.
    Busca A; Locatelli F; Marmont F; Audisio E; Falda M
    Haematologica; 2003 Jul; 88(7):837-9. PubMed ID: 12857569
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Hommann M; Scheele J
    Int Immunopharmacol; 2005 Jan; 5(1):107-15. PubMed ID: 15589468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil for lupus related myelopathy.
    Mok CC; Mak A; To CH
    Ann Rheum Dis; 2006 Jul; 65(7):971-3. PubMed ID: 16769787
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
    Baltatzis S; Tufail F; Yu EN; Vredeveld CM; Foster CS
    Ophthalmology; 2003 May; 110(5):1061-5. PubMed ID: 12750115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete but transient relief of chronic cluster headache with mycophenolate mofetil.
    Rozen TD
    Headache; 2004 Sep; 44(8):818-20. PubMed ID: 15330831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.